{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:53:34Z","timestamp":1792976014978,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170587"],"award-info":[{"award-number":["82170587"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFJQ0054"],"award-info":[{"award-number":["2024NSFJQ0054"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00535-025-02293-1","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T03:57:49Z","timestamp":1757390269000},"page":"1535-1553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hic-5 deficiency attenuates MAFLD by inhibiting neutrophils migration via the CXCL1-CXCR2 axis"],"prefix":"10.1007","volume":"60","author":[{"given":"Bingyu","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenguang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"2293_CR1","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/j.cgh.2021.05.029","volume":"19","author":"VH Nguyen","year":"2021","unstructured":"Nguyen VH, Le MH, Cheung RC, Nguyen MH. Differential clinical characteristics and mortality outcomes in persons With NAFLD and\/or MAFLD. Clin Gastroenterol Hepatol. 2021;19:2172-2181.e2176. https:\/\/doi.org\/10.1016\/j.cgh.2021.05.029.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2293_CR2","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/hep.26717","volume":"59","author":"MJ Armstrong","year":"2014","unstructured":"Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2014;59:1174\u201397. https:\/\/doi.org\/10.1002\/hep.26717.","journal-title":"Hepatology"},{"key":"2293_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2293_CR4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908\u201322. https:\/\/doi.org\/10.1038\/s41591-018-0104-9.","journal-title":"Nat Med"},{"key":"2293_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7:851\u201361. https:\/\/doi.org\/10.1016\/s2468-1253(22)00165-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2293_CR6","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/hep.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335\u201347. https:\/\/doi.org\/10.1097\/hep.0000000000000004.","journal-title":"Hepatology"},{"key":"2293_CR7","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","volume":"29","author":"C Gofton","year":"2023","unstructured":"Gofton C, Upendran Y, Zheng MH, George J. MAFLD: how is it different from NAFLD? Clin Mol Hepatol. 2023;29:S17-s31. https:\/\/doi.org\/10.3350\/cmh.2022.0367.","journal-title":"Clin Mol Hepatol"},{"key":"2293_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera A, Soehnlein O, Kenne E. Neutrophils in chronic inflammatory diseases. Cell Mol Immunol. 2022;19:177\u201391. https:\/\/doi.org\/10.1038\/s41423-021-00832-3.","journal-title":"Cell Mol Immunol"},{"key":"2293_CR9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jhep.2021.07.032","volume":"75","author":"H Wang","year":"2021","unstructured":"Wang H, et al. Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis. J Hepatol. 2021;75:1271\u201383. https:\/\/doi.org\/10.1016\/j.jhep.2021.07.032.","journal-title":"J Hepatol"},{"key":"2293_CR10","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/hep.29914","volume":"68","author":"DJ van der Windt","year":"2018","unstructured":"van der Windt DJ, et al. Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology. 2018;68:1347\u201360. https:\/\/doi.org\/10.1002\/hep.29914.","journal-title":"Hepatology"},{"key":"2293_CR11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/hep.31031","volume":"72","author":"S Hwang","year":"2020","unstructured":"Hwang S, et al. Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets. Hepatology. 2020;72:412\u201329. https:\/\/doi.org\/10.1002\/hep.31031.","journal-title":"Hepatology"},{"key":"2293_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.31658","volume":"74","author":"X Hou","year":"2021","unstructured":"Hou X, et al. Myeloid-cell-specific IL-6 signaling promotes microRNA-223-enriched exosome production to attenuate NAFLD-associated fibrosis. Hepatology. 2021;74:116\u201332. https:\/\/doi.org\/10.1002\/hep.31658.","journal-title":"Hepatology"},{"key":"2293_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/jci141513","author":"Y He","year":"2021","unstructured":"He Y, et al. Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/jci141513.","journal-title":"J Clin Invest"},{"key":"2293_CR14","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2353\/ajpath.2009.080999","volume":"175","author":"SS Rensen","year":"2009","unstructured":"Rensen SS, et al. Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am J Pathol. 2009;175:1473\u201382. https:\/\/doi.org\/10.2353\/ajpath.2009.080999.","journal-title":"Am J Pathol"},{"key":"2293_CR15","doi-asserted-by":"publisher","first-page":"1337241","DOI":"10.3389\/fimmu.2024.1337241","volume":"15","author":"K Liu","year":"2024","unstructured":"Liu K, et al. Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk. Front Immunol. 2024;15:1337241. https:\/\/doi.org\/10.3389\/fimmu.2024.1337241.","journal-title":"Front Immunol"},{"key":"2293_CR16","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2022.5194","author":"S Yao","year":"2022","unstructured":"Yao S, et al. Physiological and pathological roles of Hic-5 in several organs (Review). Int J Mol Med. 2022. https:\/\/doi.org\/10.3892\/ijmm.2022.5194.","journal-title":"Int J Mol Med"},{"key":"2293_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41419-019-2114-z","volume":"10","author":"X Du","year":"2019","unstructured":"Du X, et al. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression. Cell Death Dis. 2019;10:873. https:\/\/doi.org\/10.1038\/s41419-019-2114-z.","journal-title":"Cell Death Dis"},{"key":"2293_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101195","volume":"6","author":"M Noguchi","year":"2024","unstructured":"Noguchi M, et al. Hic-5 antisense oligonucleotide inhibits advanced hepatic fibrosis and steatosis in vivo. JHEP Rep. 2024;6:101195. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101195.","journal-title":"JHEP Rep"},{"key":"2293_CR19","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1038\/s41388-017-0074-2","volume":"37","author":"GJ Goreczny","year":"2018","unstructured":"Goreczny GJ, Forsythe IJ, Turner CE. Hic-5 regulates fibrillar adhesion formation to control tumor extracellular matrix remodeling through interaction with tensin1. Oncogene. 2018;37:1699\u2013713. https:\/\/doi.org\/10.1038\/s41388-017-0074-2.","journal-title":"Oncogene"},{"key":"2293_CR20","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1161\/atvbaha.114.305185","volume":"35","author":"I Fernandez","year":"2015","unstructured":"Fernandez I, et al. Hic-5 mediates TGF\u03b2-induced adhesion in vascular smooth muscle cells by a Nox4-dependent mechanism. Arterioscler Thromb Vasc Biol. 2015;35:1198\u2013206. https:\/\/doi.org\/10.1161\/atvbaha.114.305185.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2293_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jhep.2015.08.026","volume":"64","author":"XF Lei","year":"2016","unstructured":"Lei XF, et al. Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice. J Hepatol. 2016;64:110\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2015.08.026.","journal-title":"J Hepatol"},{"key":"2293_CR22","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.tig.2021.06.014","volume":"38","author":"RL Kan","year":"2022","unstructured":"Kan RL, Chen J, Sallam T. Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation. Trends Genet. 2022;38:182\u201393. https:\/\/doi.org\/10.1016\/j.tig.2021.06.014.","journal-title":"Trends Genet"},{"key":"2293_CR23","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.1093\/nar\/gkab378","volume":"49","author":"S Oerum","year":"2021","unstructured":"Oerum S, Meynier V, Catala M, Tisn\u00e9 C. A comprehensive review of m6A\/m6Am RNA methyltransferase structures. Nucleic Acids Res. 2021;49:7239\u201355. https:\/\/doi.org\/10.1093\/nar\/gkab378.","journal-title":"Nucleic Acids Res"},{"key":"2293_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He L, et al. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18:176. https:\/\/doi.org\/10.1186\/s12943-019-1109-9.","journal-title":"Mol Cancer"},{"key":"2293_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/jci177932","author":"Y Ge","year":"2024","unstructured":"Ge Y, et al. Elevated WTAP promotes hyperinflammation by increasing m6A modification in inflammatory disease models. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/jci177932.","journal-title":"J Clin Invest"},{"key":"2293_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in cancer progression. Mol Cancer. 2020;19:88. https:\/\/doi.org\/10.1186\/s12943-020-01204-7.","journal-title":"Mol Cancer"},{"key":"2293_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-020-01172-y","volume":"19","author":"M Chen","year":"2020","unstructured":"Chen M, Wong CM. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis. Mol Cancer. 2020;19:44. https:\/\/doi.org\/10.1186\/s12943-020-01172-y.","journal-title":"Mol Cancer"},{"key":"2293_CR28","doi-asserted-by":"publisher","first-page":"W548","DOI":"10.1093\/nar\/gkz479","volume":"47","author":"Q Liu","year":"2019","unstructured":"Liu Q, Gregory RI. RNAmod: an integrated system for the annotation of mRNA modifications. Nucleic Acids Res. 2019;47:W548-w555. https:\/\/doi.org\/10.1093\/nar\/gkz479.","journal-title":"Nucleic Acids Res"},{"key":"2293_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21:14. https:\/\/doi.org\/10.1186\/s12943-022-01500-4.","journal-title":"Mol Cancer"},{"key":"2293_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12943-019-1053-8","volume":"18","author":"Y Chen","year":"2019","unstructured":"Chen Y, et al. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Mol Cancer. 2019;18:127. https:\/\/doi.org\/10.1186\/s12943-019-1053-8.","journal-title":"Mol Cancer"},{"key":"2293_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102378","volume":"54","author":"R Sun","year":"2022","unstructured":"Sun R, et al. The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis. Redox Biol. 2022;54:102378. https:\/\/doi.org\/10.1016\/j.redox.2022.102378.","journal-title":"Redox Biol"},{"key":"2293_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41392-020-00453-8","volume":"6","author":"Q Li","year":"2021","unstructured":"Li Q, et al. HIF-1\u03b1-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. Signal Transduct Target Ther. 2021;6:76. https:\/\/doi.org\/10.1038\/s41392-020-00453-8.","journal-title":"Signal Transduct Target Ther"},{"key":"2293_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/hc9.0000000000000046","volume":"7","author":"J Tan","year":"2023","unstructured":"Tan J, et al. Roles of RNA m6A modification in nonalcoholic fatty liver disease. Hepatol Commun. 2023;7:e0046. https:\/\/doi.org\/10.1097\/hc9.0000000000000046.","journal-title":"Hepatol Commun"},{"key":"2293_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41392-024-01797-1","volume":"9","author":"YF Wang","year":"2024","unstructured":"Wang YF, et al. METTL14 downregulation drives S100A4(+) monocyte-derived macrophages via MyD88\/NF-\u03baB pathway to promote MAFLD progression. Signal Transduct Target Ther. 2024;9:91. https:\/\/doi.org\/10.1038\/s41392-024-01797-1.","journal-title":"Signal Transduct Target Ther"},{"key":"2293_CR35","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.cmet.2024.07.014","volume":"36","author":"B Zhou","year":"2024","unstructured":"Zhou B, et al. Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11. Cell Metab. 2024;36:2228-2244.e2227. https:\/\/doi.org\/10.1016\/j.cmet.2024.07.014.","journal-title":"Cell Metab"},{"key":"2293_CR36","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ymthe.2021.09.016","volume":"30","author":"Z Peng","year":"2022","unstructured":"Peng Z, et al. METTL3-m(6)A-rubicon axis inhibits autophagy in nonalcoholic fatty liver disease. Mol Ther. 2022;30:932\u201346. https:\/\/doi.org\/10.1016\/j.ymthe.2021.09.016.","journal-title":"Mol Ther"},{"key":"2293_CR37","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.tem.2023.09.002","volume":"34","author":"P Luo","year":"2023","unstructured":"Luo P, Li S, Jing W, Tu J, Long X. N(6)-methyladenosine RNA modification in nonalcoholic fatty liver disease. Trends Endocrinol Metab. 2023;34:838\u201348. https:\/\/doi.org\/10.1016\/j.tem.2023.09.002.","journal-title":"Trends Endocrinol Metab"},{"key":"2293_CR38","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1126\/science.287.5455.1037","volume":"287","author":"G Servant","year":"2000","unstructured":"Servant G, et al. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science. 2000;287:1037\u201340. https:\/\/doi.org\/10.1126\/science.287.5455.1037.","journal-title":"Science"},{"key":"2293_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature01137","volume":"420","author":"J Hirosumi","year":"2002","unstructured":"Hirosumi J, et al. A central role for JNK in obesity and insulin resistance. Nature. 2002;420:333\u20136. https:\/\/doi.org\/10.1038\/nature01137.","journal-title":"Nature"},{"key":"2293_CR40","doi-asserted-by":"publisher","first-page":"16454","DOI":"10.1073\/pnas.0607626103","volume":"103","author":"G Solinas","year":"2006","unstructured":"Solinas G, Naugler W, Galimi F, Lee MS, Karin M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc Natl Acad Sci U S A. 2006;103:16454\u20139. https:\/\/doi.org\/10.1073\/pnas.0607626103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2293_CR41","doi-asserted-by":"publisher","first-page":"10741","DOI":"10.1073\/pnas.0603509103","volume":"103","author":"G Tuncman","year":"2006","unstructured":"Tuncman G, et al. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci U S A. 2006;103:10741\u20136. https:\/\/doi.org\/10.1073\/pnas.0603509103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2293_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102438","volume":"56","author":"S Wang","year":"2022","unstructured":"Wang S, et al. CXCL1-CXCR2 signalling mediates hypertensive retinopathy by inducing macrophage infiltration. Redox Biol. 2022;56:102438. https:\/\/doi.org\/10.1016\/j.redox.2022.102438.","journal-title":"Redox Biol"},{"key":"2293_CR43","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","volume":"163","author":"H Chen","year":"2022","unstructured":"Chen H, et al. METTL3 inhibits antitumor immunity by targeting m(6)A-BHLHE41-CXCL1\/CXCR2 axis to promote colorectal cancer. Gastroenterology. 2022;163:891\u2013907. https:\/\/doi.org\/10.1053\/j.gastro.2022.06.024.","journal-title":"Gastroenterology"},{"key":"2293_CR44","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/eurheartj\/ehy085","volume":"39","author":"L Wang","year":"2018","unstructured":"Wang L, et al. CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration. Eur Heart J. 2018;39:1818\u201331. https:\/\/doi.org\/10.1093\/eurheartj\/ehy085.","journal-title":"Eur Heart J"},{"key":"2293_CR45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180992","author":"XX Liu","year":"2020","unstructured":"Liu XX, et al. Endothelial Cdk5 deficit leads to the development of spontaneous epilepsy through CXCL1\/CXCR2-mediated reactive astrogliosis. J Exp Med. 2020. https:\/\/doi.org\/10.1084\/jem.20180992.","journal-title":"J Exp Med"},{"key":"2293_CR46","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1111\/cas.15901","volume":"114","author":"M Hayashi","year":"2023","unstructured":"Hayashi M, et al. Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axis. Cancer Sci. 2023;114:3666\u201378. https:\/\/doi.org\/10.1111\/cas.15901.","journal-title":"Cancer Sci"},{"key":"2293_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008662","author":"G Xiong","year":"2024","unstructured":"Xiong G, et al. CD276 regulates the immune escape of esophageal squamous cell carcinoma through CXCL1-CXCR2 induced NETs. J Immunother Cancer. 2024. https:\/\/doi.org\/10.1136\/jitc-2023-008662.","journal-title":"J Immunother Cancer"},{"key":"2293_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa055","author":"S Deng","year":"2021","unstructured":"Deng S, et al. M6A2Target: a comprehensive database for targets of m6A writers, erasers and readers. Brief Bioinform. 2021. https:\/\/doi.org\/10.1093\/bib\/bbaa055.","journal-title":"Brief Bioinform"},{"key":"2293_CR49","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","volume":"142","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142:1592\u2013609. https:\/\/doi.org\/10.1053\/j.gastro.2012.04.001.","journal-title":"Gastroenterology"},{"key":"2293_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/nu14173662","author":"T Xu","year":"2022","unstructured":"Xu T, et al. Hawk tea flavonoids as natural hepatoprotective agents alleviate acute liver damage by reshaping the intestinal microbiota and modulating the Nrf2 and NF-\u03baB signaling pathways. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14173662.","journal-title":"Nutrients"},{"key":"2293_CR51","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1038\/onc.2016.422","volume":"36","author":"GJ Goreczny","year":"2017","unstructured":"Goreczny GJ, Ouderkirk-Pecone JL, Olson EC, Krendel M, Turner CE. Hic-5 remodeling of the stromal matrix promotes breast tumor progression. Oncogene. 2017;36:2693\u2013703. https:\/\/doi.org\/10.1038\/onc.2016.422.","journal-title":"Oncogene"},{"key":"2293_CR52","doi-asserted-by":"publisher","first-page":"1292679","DOI":"10.3389\/fimmu.2023.1292679","volume":"14","author":"P Fa","year":"2023","unstructured":"Fa P, Ke BG, Dupre A, Tsung A, Zhang H. The implication of neutrophil extracellular traps in nonalcoholic fatty liver disease. Front Immunol. 2023;14:1292679. https:\/\/doi.org\/10.3389\/fimmu.2023.1292679.","journal-title":"Front Immunol"},{"key":"2293_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107424","volume":"205","author":"V Kain","year":"2020","unstructured":"Kain V, Halade GV. Role of neutrophils in ischemic heart failure. Pharmacol Ther. 2020;205:107424. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107424.","journal-title":"Pharmacol Ther"},{"key":"2293_CR54","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1152\/physrev.00012.2018","volume":"99","author":"PX Liew","year":"2019","unstructured":"Liew PX, Kubes P. The neutrophil\u2019s role during health and disease. Physiol Rev. 2019;99:1223\u201348. https:\/\/doi.org\/10.1152\/physrev.00012.2018.","journal-title":"Physiol Rev"},{"key":"2293_CR55","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jaci.2022.02.008","volume":"149","author":"S Shao","year":"2022","unstructured":"Shao S, Xue K, Wang G. Neutrophils in neutrophilic dermatoses: emerging roles and promising targeted therapies. J Allergy Clin Immunol. 2022;149:1203\u20135. https:\/\/doi.org\/10.1016\/j.jaci.2022.02.008.","journal-title":"J Allergy Clin Immunol"},{"key":"2293_CR56","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1711","volume":"8","author":"J Park","year":"2016","unstructured":"Park J, et al. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci Transl Med. 2016;8:361ra138. https:\/\/doi.org\/10.1126\/scitranslmed.aag1711.","journal-title":"Sci Transl Med"},{"key":"2293_CR57","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41423-020-0412-0","volume":"17","author":"M Metzemaekers","year":"2020","unstructured":"Metzemaekers M, Gouwy M, Proost P. Neutrophil chemoattractant receptors in health and disease: double-edged swords. Cell Mol Immunol. 2020;17:433\u201350. https:\/\/doi.org\/10.1038\/s41423-020-0412-0.","journal-title":"Cell Mol Immunol"},{"key":"2293_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107609","volume":"97","author":"S Chen","year":"2021","unstructured":"Chen S, Guo H, Xie M, Zhou C, Zheng M. Neutrophil: an emerging player in the occurrence and progression of metabolic associated fatty liver disease. Int Immunopharmacol. 2021;97:107609. https:\/\/doi.org\/10.1016\/j.intimp.2021.107609.","journal-title":"Int Immunopharmacol"},{"key":"2293_CR59","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1097\/hep.0000000000000762","volume":"81","author":"Y Xia","year":"2025","unstructured":"Xia Y, et al. Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of HSC. Hepatology. 2025;81:947\u201361. https:\/\/doi.org\/10.1097\/hep.0000000000000762.","journal-title":"Hepatology"},{"key":"2293_CR60","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/hep.0000000000000045","volume":"79","author":"M Cunningham","year":"2024","unstructured":"Cunningham M, Gupta R, Butler M. Checkpoint inhibitor hepatotoxicity: pathogenesis and management. Hepatology. 2024;79:198\u2013212. https:\/\/doi.org\/10.1097\/hep.0000000000000045.","journal-title":"Hepatology"},{"key":"2293_CR61","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1136\/gutjnl-2021-326259","volume":"71","author":"J Leslie","year":"2022","unstructured":"Leslie J, et al. CXCR2 inhibition enables NASH-HCC immunotherapy. Gut. 2022;71:2093\u2013106. https:\/\/doi.org\/10.1136\/gutjnl-2021-326259.","journal-title":"Gut"},{"key":"2293_CR62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jhep.2024.02.009","volume":"81","author":"P Xie","year":"2024","unstructured":"Xie P, et al. CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma. J Hepatol. 2024;81:93\u2013107. https:\/\/doi.org\/10.1016\/j.jhep.2024.02.009.","journal-title":"J Hepatol"},{"key":"2293_CR63","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/circulationaha.121.056730","volume":"146","author":"H Zhu","year":"2022","unstructured":"Zhu H, et al. Identification of pathogenic immune cell subsets associated with checkpoint inhibitor-induced myocarditis. Circulation. 2022;146:316\u201335. https:\/\/doi.org\/10.1161\/circulationaha.121.056730.","journal-title":"Circulation"},{"key":"2293_CR64","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.tem.2010.08.010","volume":"21","author":"MJ Czaja","year":"2010","unstructured":"Czaja MJ. JNK regulation of hepatic manifestations of the metabolic syndrome. Trends Endocrinol Metab. 2010;21:707\u201313. https:\/\/doi.org\/10.1016\/j.tem.2010.08.010.","journal-title":"Trends Endocrinol Metab"},{"key":"2293_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174079","volume":"901","author":"R Garg","year":"2021","unstructured":"Garg R, et al. JNK signaling pathway in metabolic disorders: an emerging therapeutic target. Eur J Pharmacol. 2021;901:174079. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174079.","journal-title":"Eur J Pharmacol"},{"key":"2293_CR66","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1152\/physrev.2001.81.2.807","volume":"81","author":"JM Kyriakis","year":"2001","unstructured":"Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 2001;81:807\u201369. https:\/\/doi.org\/10.1152\/physrev.2001.81.2.807.","journal-title":"Physiol Rev"},{"key":"2293_CR67","doi-asserted-by":"publisher","first-page":"16809","DOI":"10.1073\/pnas.0805677105","volume":"105","author":"JL Stebbins","year":"2008","unstructured":"Stebbins JL, et al. Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proc Natl Acad Sci U S A. 2008;105:16809\u201313. https:\/\/doi.org\/10.1073\/pnas.0805677105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2293_CR68","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1172\/jci37156","volume":"118","author":"L Hui","year":"2008","unstructured":"Hui L, Zatloukal K, Scheuch H, Stepniak E, Wagner EF. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J Clin Invest. 2008;118:3943\u201353. https:\/\/doi.org\/10.1172\/jci37156.","journal-title":"J Clin Invest"},{"key":"2293_CR69","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/33340","volume":"392","author":"M Baggiolini","year":"1998","unstructured":"Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392:565\u20138. https:\/\/doi.org\/10.1038\/33340.","journal-title":"Nature"},{"key":"2293_CR70","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/nejm199802123380706","volume":"338","author":"AD Luster","year":"1998","unstructured":"Luster AD. Chemokines\u2013chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436\u201345. https:\/\/doi.org\/10.1056\/nejm199802123380706.","journal-title":"N Engl J Med"},{"key":"2293_CR71","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/s41467-018-03966-7","volume":"9","author":"M Taki","year":"2018","unstructured":"Taki M, et al. Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation. Nat Commun. 2018;9:1685. https:\/\/doi.org\/10.1038\/s41467-018-03966-7.","journal-title":"Nat Commun"},{"key":"2293_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051237","author":"B Sharma","year":"2019","unstructured":"Sharma B, Nannuru KC, Saxena S, Varney ML, Singh RK. CXCR2: a novel mediator of mammary tumor bone metastasis. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20051237.","journal-title":"Int J Mol Sci"},{"key":"2293_CR73","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1038\/onc.2017.108","volume":"36","author":"Z Xiang","year":"2017","unstructured":"Xiang Z, et al. A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis. Oncogene. 2017;36:5122\u201333. https:\/\/doi.org\/10.1038\/onc.2017.108.","journal-title":"Oncogene"},{"key":"2293_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2024.10.033","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, et al. M6A sites in the coding region trigger translation-dependent mRNA decay. Mol Cell. 2024. https:\/\/doi.org\/10.1016\/j.molcel.2024.10.033.","journal-title":"Mol Cell"},{"key":"2293_CR75","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20:303\u201322. https:\/\/doi.org\/10.1038\/s41568-020-0253-2.","journal-title":"Nat Rev Cancer"},{"key":"2293_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101144","volume":"4","author":"Y Pan","year":"2023","unstructured":"Pan Y, et al. METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy. Cell Rep Med. 2023;4:101144. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101144.","journal-title":"Cell Rep Med"},{"key":"2293_CR77","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jhep.2020.04.009","volume":"73","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, et al. Epitranscriptomics in liver disease: basic concepts and therapeutic potential. J Hepatol. 2020;73:664\u201379. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.009.","journal-title":"J Hepatol"},{"key":"2293_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.973116","volume":"13","author":"W Cheng","year":"2022","unstructured":"Cheng W, et al. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC. Front Pharmacol. 2022;13:973116. https:\/\/doi.org\/10.3389\/fphar.2022.973116.","journal-title":"Front Pharmacol"},{"key":"2293_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217415","volume":"611","author":"X Chen","year":"2024","unstructured":"Chen X, et al. RNF5 exacerbates steatotic HCC by enhancing fatty acid oxidation via the improvement of CPT1A stability. Cancer Lett. 2024;611:217415. https:\/\/doi.org\/10.1016\/j.canlet.2024.217415.","journal-title":"Cancer Lett"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-025-02293-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-025-02293-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-025-02293-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T11:14:13Z","timestamp":1763550853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-025-02293-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":79,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2293"],"URL":"https:\/\/doi.org\/10.1007\/s00535-025-02293-1","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The use of human tissue specimens was approved by the Ethics Committee for Clinical Trials at the Affiliated Hospital of Southwest Medical University (NO. KY2022167).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}